Abbott Laboratories (NYSE:ABT)announced positive interim data from the RApid Diagnosis of Infections in the CriticAlly IlL (RADICAL) study. The RADICAL study analyzed samples from more than 180 critically ill patients with suspected severe infections and compared the results of Abbott’s technology (IRIDICA) to the current standard of care. Abbott Laboratories (NYSE:ABT) net profit margin is 13.60% and weekly performance is 2.80%. On last trading day company shares ended up $0.99. Analysts mean target price for the company is $41.41. Abbott Laboratories (NYSE:ABT) distance from 50-day simple moving average (SMA50) is 2.78%.
Shares of Johnson & Johnson (NYSE:JNJ) were the target of a significant drop in short interest in April. As of April 15th, there was short interest totalling 27,397,675 shares, a drop of 11.8% from the March 31st total of 31,078,666 shares, American Banking News.com reports. Based on an average trading volume of 9,253,381 shares, the days-to-cover ratio is currently 3.0 days. Approximately 1.0% of the company’s stock are sold short. Johnson & Johnson (NYSE:JNJ) shares advanced 0.50% in last trading session and ended the day on $101.02. JNJ Gross Margin is 69.10% and its return on assets is 11.90%. Johnson & Johnson (NYSE:JNJ) quarterly performance is 9.44%.
On May 12, Eli Lilly and Co (NYSE:LLY)said its type 2 diabetes drug was more effective than Sanofi SA’s approved drug Lantus in reducing patients’ blood sugar levels in three late-stage trials. Eli Lilly and Co (NYSE:LLY) shares moved up 1.88% in last trading session and was closed at $60.04, while trading in range of $58.76 – $60.35. Eli Lilly and Co (NYSE:LLY) year to date (YTD) performance is 19.79%.
China on Wednesday accused GlaxoSmithKline plc (ADR) (NYSE:GSK)’s former China chief of ordering subordinates to commit bribery that resulted in billions of yuan in revenue. At a press briefing, officials from China’s Ministry of Public Security alleged that the executive, U.K. national Mark Reilly, ordered his sales team and other employees to bribe hospital doctors, health care organizations and other parties on “a large scale” to boost drug sales in China. GlaxoSmithKline plc (ADR) (NYSE:GSK) ended the last trading day at $55.52. Company weekly volatility is calculated as 0.87% and price to cash ratio as 22.25. GlaxoSmithKline plc (ADR) (NYSE:GSK) showed a positive weekly performance of 0.18%.
Leave a Reply